©The Author(s) 2018.
World J Clin Cases. Nov 26, 2018; 6(14): 786-790
Published online Nov 26, 2018. doi: 10.12998/wjcc.v6.i14.786
Published online Nov 26, 2018. doi: 10.12998/wjcc.v6.i14.786
Table 2 Dried blood spot acylcarnitine results
| Blood acylcarnitine concentrations (μmol/L) | Patient | Reference range |
| Free carnitine (C0) | 5.46 ↓ | 8.60-90.0 |
| Acetylcarnitine (C2) | 3.86 ↓ | 8.00-73.4 |
| Propionylcarnitine (C3) | 0.20 N | < 6.800 |
| Butyrlycarnitine (C4) | 2.25 ↑ | < 1.200 |
| Isovalerylcarnitine (C5) | 0.18 N | < 0.600 |
| Glutarylcarnitine (C5DC) | 0.27 ↑ | < 0.210 |
| Hexanoylcarnitine (C6) | 0.52 ↑ | < 0.210 |
| Octanoylcarnitine (C8) | 2.77 ↑ | < 0.320 |
| Decanoylcarnitine (C10) | 2.18 ↑ | < 0.480 |
| Dodecanoylcarnitine (C12) | 1.37 ↑ | < 0.690 |
| Tetradecanoylcarnitine (C14) | 0.57 N | < 0.800 |
| Hexadecanoylcarnitine (C16) | 0.69 N | < 8.700 |
| Octadecenoylcarnitine (C18) | 0.76 N | < 2.240 |
- Citation: Saral NY, Aksungar FB, Aktuglu-Zeybek C, Coskun J, Demirelce O, Serteser M. Glutaric acidemia type II patient with thalassemia minor and novel electron transfer flavoprotein-A gene mutations: A case report and review of literature. World J Clin Cases 2018; 6(14): 786-790
- URL: https://www.wjgnet.com/2307-8960/full/v6/i14/786.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i14.786